The British Journal of Rheumatology, Vol 36, 1009-1011, Copyright © 1997 by British Society for Rheumatology
A Steuer and AC Keat
We have surveyed the use of methotrexate in the perioperative period in
patients with rheumatoid arthritis (RA) undergoing surgery. A total of 200
consultant rheumatologists and 200 consultant orthopaedic surgeons in the
UK were sent a postal questionnaire. Thirty-five per cent of
rheumatologists and 46% of orthopaedic surgeons were concerned that the
drug may increase the risk of post-operative complications, although
significantly less 'always' stopped the drug around the time of surgery.
There was great variation in the timing of stopping the drug with most
stopping treatment within 2 weeks before surgery and restarting within 2
weeks after surgery. The majority of clinicians surveyed (70%) felt that
national guidelines for the perioperative use of methotrexate would be
helpful.
ORIGINAL PAPERS
Perioperative use of methotrexate--a survey of clinical practice in the UK
Department of Rheumatology, Northwick Park and St Mark's Hospital, Harrow.
![]()
CiteULike
Connotea
Del.icio.us What's this?